Group | All patients (n = 67) | Group A (n = 49) | Group B (n = 18) | P value |
---|---|---|---|---|
Treatment | ||||
Oxygen therapy | 61 (91.0%) | 43 (87.8%) | 18 (100%) | 0.044 |
Nasal catheter oxygen | 49 (73.1%) | 43 (87.8%) | 6 (33.3%) | – |
Mask oxygen | 7 (10.4%) | 0 | 7 (38.9%) | – |
High flow oxygen | 3 (4.5) | 0 | 3 (16.7%) | – |
Non-invasive ventilator | 2 (3.0%) | 0 | 2 (11.1%) | – |
Glucocorticoids | 22 (32.8%) | 6 (12.2%) | 16 (88.9%) | <0.001 |
Glucocorticoids using time | 6.5 (5.0,9.0) | 7.0 (5.0,9.0) | 6.0 (5.3,8.3) | < 0.001 |
Antiviral therapy | 67 (100%) | 49 (100%) | 18 (100%) | 0.397 |